About
Company description
At Novonesis, we believe solutions rooted in biology are key to tackling the challenges our world faces.
Enzymes, functional proteins and microorganisms are our planet's tiniest, yet mightiest agents of change. When we leverage their power with science, we create biosolutions that transform the way we all produce, consume and live.
Today, we are 10,000 people worldwide whose expertise spans more than 30 different industries. All around the world, our biosolutions already create value for thousands of customers and benefit the planet.
Our biosolutions enable feeding and fueling the world more sustainably, from healthy and sustainable nutrition to biofuel. Our biosolutions also reduce the use of fossil-based resources, chemicals, energy and water. And this is just the beginning. The potential is almost endless.
The time for biosolutions is now. And by working closely with our partners and customers, we will continue to challenge conventional thinking and transform business with biology. Together, we will create the change our world needs.
Quick facts
| Primary business activity | Manufacturer: Ingredients / Additives |
|---|---|
| Affiliated categories: | Enzymes |Probiotics More |
Upcoming events
Vitafoods Europe 2025
20 - 22 May 2025 Barcelona, Spain Visit us at stand 4D8 Book a meeting See our Exhibitor Profile See full Exhibitor ListVitafoods Asia 2025
17 - 19 Sept 2025 Bangkok, Thailand Visit us at stand A01 Book a meeting See our Exhibitor Profile See full Exhibitor ListFi Europe 2025
2 - 4 December 2025 Paris Expo Porte de Versailles Visit us at stand 40H90 Book a meeting See our Exhibitor Profile See full Exhibitor ListRecently at
Fi Europe 2024
19 - 21 Nov 2024 Frankfurt, Germany We were at stand 3.1H90 See our Exhibitor Profile See full Exhibitor ListVitafoods Europe 2024
14 - 16 May 2024 - Geneva, Switzerland We were at stand H99 See our Exhibitor Profile See full Exhibitor ListNews about Novonesis
2 Jul 2020
Novozymes acquires PrecisionBiotics Group
Danish biotech company Novozymes announced its acquisition of Irish probiotics firm PrecisionBiotics Group for €80 million.
Read more